Tags:BiopharmaBusinessDeviceMarketMarketingMedicalMedTechPharmacySales
Swixx BioPharma is designed to fully replace biopharma, OTC and medical device multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE, that the multinational chooses not to enter, or to exit
Likes
113
Location: Switzerland, Zug, Baar
Member count: 201-500
Phone: +41 41 552 34 40
Total raised: $121.88448M
Founded date: 2013

Investors 1

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
21.05.2021-$121.88448...-startuptic...

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
28.05.2021Ad hoc ann...Swixx BioPharma, a privately h...--hbmhealthc...
21.05.2021Swixx BioP...The strong Swiss pharma and bi...Investment...-startuptic...
21.05.2021Swixx BioP... The strong Swiss pharma and ...Financing-startuptic...